NHS Dudley Health Economy Medicines Formulary
Home > 8 Malignant disease and immunosuppression > 8.1 Cytotoxic drugs > 8.1.5 Other antineoplastic drugs > Cervical cancer (recurrent) - topotecan - NICE TAG TA183

Cervical cancer (recurrent) - topotecan - NICE TAG TA183

1.1 Topotecan in combination with cisplatin is recommended as a treatment option for women with recurrent or stage IVB cervical cancer only if they have not previously received cisplatin.

1.2 Women who have previously received cisplatin and are currently being treated with topotecan in combination with cisplatin for recurrent and stage IVB cervical cancer should have the option to continue their therapy until they and their clinicians consider it appropriate to stop.

https://www.nice.org.uk/guidance/TA183

Site by Devopa
© Copyright 2019 NHS. All rights reserved.